What medical and pharmaceutical/bioscience/medical device meeting planners and continuing medical education professionals need to know to plan meetings and CME activities for healthcare professionals.
Recommended reading from Anne Taylor-Vaisey: 1: J Clin Pharmacol. 2006 Apr;46(4):394-7. Clinical pharmacology of the appeals and exception process: the interface of the patient, physician, and insurance company to assure appropriate care under...
Recommended reading from Anne Taylor-Vaisey: The article below was just published online in the Journal of Medical Internet Research. Free html full text is available to all. You have to register to access PDF versions (no charge for registration)...
Recommended reading from Anne Taylor-Vaisey: This supplement of the Canadian Respiratory Journal contains the proceedings of an April 2005 workshop on guideline implementation...
The Sarbanes-Oxley Act, the spawn of the Enron, et al scandals, is important to know about and comply with. But I've always thought it was a little boring to learn about. Not when David Kaufman of Acquis Consulting Group is leading the session...
Like most of corporate America, pharma companies are consolidating their meeting spend and tracking cost savings and cost avoidances. This morning, I attended two really excellent sessions at the Pharmaceutical Meeting Planners Forum by pharma...
More whining from the Pharmaceutical Meeting Planners Forum: I thought I was a goner by 8 last night, but somehow managed to hang in for dinner (excellent prawns at the JW Steakhouse here in the hotel) and caught a second wind that kept me up once...
